Cytotoxic T lymphocytes: All roads lead to death

Nature Reviews Immunology

Volumn 2, Issue 6, 2002, Pages 401-409

  Barry, Michele ^a   Bleackley, R Chris ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; DIPEPTIDYL PEPTIDASE; FAS LIGAND; GRANULYSIN; GRANZYME A; GRANZYME B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; PROTEINASE; GRANZYME; GZMB PROTEIN, HUMAN; GZMB PROTEIN, MOUSE; GZMB PROTEIN, RAT; SERINE PROTEINASE;

AMEBIASIS; ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTATION; APOPTOSIS; BACTERIAL INFECTION; CELL DEATH; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; ENTAMOEBA HISTOLYTICA; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS; VIRUS INFECTION; ANIMAL; AUTOIMMUNITY; BIOLOGICAL MODEL; CYTOTOXICITY; ENZYMOLOGY; IMMUNOLOGY; RAT; VIRUS;

ANIMALS; AUTOIMMUNITY; CELL DEATH; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; GRAFT VS HOST DISEASE; GRANZYMES; HUMANS; KILLER CELLS, NATURAL; MICE; MODELS, IMMUNOLOGICAL; RATS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC; VIRUSES;

EID: 0036595397     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri819     Document Type: Review

References (110)

1. Geiger, B., Rosen, D. & Berke, G. Spatial relationships of microtubule-organizing centers and the contact area of cytotoxic T lymphocytes and target cells. J. Cell Biol. 95, 137-143 (1982).
2. Kupfer, A. & Dennert, G. Reorientation of the microtubule-organizing center and the Golgi apparatus in cloned cytotoxic lymphocytes triggered by binding to lysable target cells. J. Immunol. 133, 2762-2766 (1984).
3. Yannelli, J. R., Sullivan, J. A., Mande, G. L. & Engelhard, V. H. Reorientation and fusion of cytotoxic T-lymphocyte granules after interaction with target cells as determined by high-resolution cinemicrography. J. Immunol. 136, 377-382 (1986).
4. Zagury, D. Direct analysis of individual killer T cells: susceptibility of target cells to lysis and secretion of hydrolytic enzymes by CTL. Adv. Exp. Med. Biol. 146, 149-169 (1982).
5. Henkart, P. A. Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 3, 31-58 (1985). An authoritative review of the early work on cell-mediated cytotoxicity.
6. Helgason, C. D., Prendergast, J. A., Berke, G. & Bleackley, R. C. Peritoneal exudate lymphocyte and mixed lymphocyte culture hybridomas are cytolytic in the absence of cytotoxic cell proteinases and perforin. Eur. J. Immunol. 22, 3187-3190 (1992).
7. Ostergaard, H. L., Kane, K. P., Mescher, M. F. & Clark, W. R. Cytotoxic T-lymphocyte-mediated lysis without release of serine esterase. Nature 330, 71-72 (1987).
8. 2+-independent T-cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200 (1993).
9. Santamaria, P. Effector lymphocytes in autoimmunity. Curr. Opin. Immunol. 13, 663-669 (2001).
10. Kagi, D. et al. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 186, 989-997 (1997).
11. + T-cell-mediated insulin-dependent diabetes mellitus. J. Immunol. 163, 4335-4341 (1999).
12. Itoh, N. et al. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186, 613-618 (1997).
13. Su, X. et al. Significant role for Fas in the pathogenesis of autoimmune diabetes. J. Immunol. 164, 2523-2532 (2000).
14. + T lymphocytes in transgenic nonobese diabetic mice. J. Clin. Invest. 103, 1201-1209 (1999).
15. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449-1456 (1995). A comprehensive summary of the discovery and function of the FAS protein.
16. Krammer, P. H. CD95's deadly mission in the immune system. Nature 407, 789-795 (2000).
17. Peter, M. E. & Krammer, P. H. Mechanisms of CD95 (APO-1/Fas) -mediated apoptosis. Curr. Opin. Immunol. 10, 545-551 (1998).
18. Kagi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37 (1994).
19. Kojima, H. et al. Two distinct pathways of specific killing revealed by perforin-mutant cytotoxic T lymphocytes. Immunity 1, 357-364 (1994).
20. Lowin, B., Beermann, F., Schmidt, A. & Tschopp, J. A null mutation in the perforin gene impairs cytolytic T-lymphocyte- and natural-killer-cell-mediated cytotoxicity. Proc. Natl Acad. Sci. USA 91, 11571-11575 (1994).
21. Kagi, D. et al. Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 265, 528-530 (1994).
22. Smyth, M. J. et al. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192, 755-760 (2000).
23. van den Broek, M. E. et al. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184, 1781-1790 (1996).
24. Dennert, G. & Podack, E. R. Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes. J. Exp. Med. 157, 1483-1495 (1983).
25. Dourmashkin, R. R., Deteix, P., Simone, C. B. & Henkart, P. Electron microscopic demonstration of lesions in target-cell membranes associated with antibody-dependent cellular cytotoxicity. Clin. Exp. Immunol. 42, 554-560 (1980).
26. Podack, E. R. & Dennert, G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 302, 442-445 (1983).
27. Shresta, S., Graubert, T. A., Thomas, D. A., Raptis, S. Z. & Ley, T. J. Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity 10, 595-605 (1999). This study indicates synergy between granzymes A and B in vivo and shows that granzyme-deficient CTLs are less effective at mediating graft-versus-host disease in vivo.
28. Stinchcombe, J. C., Bossi, G., Booth, S. & Griffiths, G. M. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15, 751-761 (2001).
29. Edwards, K. M., Kam, C. M., Powers, J. C. & Trapani, J. A. The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme-B-containing endosomes. J. Biol. Chem. 274, 30468-30473 (1999).
30. Froelich, C. J. et al. New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomomic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem. 271, 29073-29079 (1996). The first demonstration that granzyme B can bind to a receptor on the surface of target cells.
31. Jans, D. A. et al. Nuclear targeting of the serine protease granzyme A (fragmentin-1). J. Cell. Sci. 111, 2645-2654 (1998).
32. Pinkoski, M. J. et al. Entry and trafficking of granzyme B in target cells during granzyme-B-perforin-mediated apoptosis. Blood 92, 1044-1054 (1998). This study describes the uptake of granzyme B into endosomes and its subsequent release by perforin.
33. Shi, L. et al. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. J. Exp. Med. 185, 855-866 (1997).
34. Browne, K. A. et al. Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin. Mol. Cell Biol. 19, 8604-8615 (1999). The idea that granzyme B gains entry into target cells by a transmembrane perforin channel is challenged by this study.
35. Motyka, B. et al. Mannose-6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T-cell-induced apoptosis. Cell 103, 491-500 (2000). This study reveals that the receptor for granzyme B is the mannose-6-phosphate/insulin-like growth factor receptor.
36. Murphy, M. E. et al. Comparative molecular model building of two serine proteinases from cytotoxic T lymphocytes. Proteins 4, 190-204 (1988).
37. Harris, J. L., Peterson, E. P. Hudig, D., Thornberry, N. A. & Craik, C. S. Definition and redesign of the extended substrate specificity of granzyme B. J. Biol. Chem 273, 27364-27373 (1998).
38. Thornberry, N. A. et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911 (1997).
39. Estebanez-Perpina, E. et al. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue. Biol. Chem. 381, 1203-1214 (2000).
40. Rotonda, J. et al. The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1. Chem. Biol. 8, 357-368 (2001).
41. Waugh, S. M., Harris, J. L., Fletterick, R. & Craik, C. S. The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity. Nature Struct. Biol. 7, 762-765 (2000). The first three-dimensional structure of granzyme B to be published.
42. Darmon, A. J., Nicholson, D. W. & Bleackley, R. C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377, 446-448 (1995). The discovery that granzyme B activates apoptosis by means of the cleavage and activation of caspases.
43. Atkinson, E. A. et al. Cytotoxic T-lymphocyte-assisted suicide. Caspase-3 activation is primary the result of the direct action of granzyme B. J. Biol. Chem. 273, 21261-21266 (1998).
44. Medema, J. P. et al. Cleavage of FLICE(caspase-8) by granzyme B during cytotoxic T-lymphocyte-induced apoptosis. Eur. J. Immunol. 27, 3492-3498 (1997).
45. Yang, X. et al. Granzyme B mimics apical caspases. Description of a unified pathway for trans-activation of executioner caspase-3 and -7. J. Biol. Chem. 273, 34278-34283 (1998).
46. Andrade, F. et al. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 8, 451-460 (1998).
47. Browne, K. A., Johnstone, R. W., Jans, D. A. & Trapani, J. A. Filamin (280-kDa actin-binding protein) is a caspase substrate and is also cleaved directly by the cytotoxic T lymphocyte protease granzyme B during apoptosis. J. Biol. Chem. 275, 39262-39266 (2000).
48. Casciola-Rosen, L., Andrade, F., Ulanet, D., Wong, W. B. & Rosen, A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 190, 815-826 (1999).
49. Kroemer, G. & Reed, J. C. Mitochondrial control of cell death. Nature Med. 6, 513-519 (2000).
50. Heibein, J. A., Barry, M., Motyka, B. & Bleackley, R. C. Granzyme-B-induced loss of mitochondrial inner membrane potential (Delta Psi m) and cytochrome c release are caspase independent. J. Immunol. 163, 4683-4693 (1999).
51. MacDonald, G., Shi, L., Vande Velde, C., Lieberman, J. & Greenberg, A. H. Mitochondria-dependent and -independent regulation of granzyme-B-induced apoptosis. J. Exp. Med. 189, 131-144 (1999).
52. Alimonti, J. B., Shi, L., Baijal, P. K. & Greenberg, A. H. Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition. J. Biol. Chem. 276, 6974-6982 (2001).
53. Barry, M. et al. Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol. Cell. Biol. 20, 3781-3794 (2000). A demonstration that granzyme B can proteotytically cleave the pro-apoptotic protein BID in cells.
54. Heibein, J. A. et al. Granzyme-B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J. Exp. Med. 192, 1391-1402 (2000).
55. Pinkoski, M. J. et al. Granzyme-B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway. J. Biol. Chem. 276, 12060-12067 (2001).
56. Sutton, V. R. et al. Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme-B-mediated caspase activation. J. Exp. Med. 192, 1403-1414 (2000). This study shows that the cleavage of BID by granzyme B is required for initiation of apoptosis.
57. Li, H., Zhu, H., Xu, C. J. & Yuan, J. Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501 (1998).
58. Wang, G. Q. et al. Resistance to granzyme-B-mediated cytochrome c release in Bak-deficient cells. J. Exp. Med. 194, 1325-1337 (2001).
59. Martinou, J. C. & Green, D. R. Breaking the mitochondrial barrier. Nature Res. Mol. Cell Biol. 2, 63-67 (2001). A recent and articulate review that discusses current theories on the leakage of proteins from mitochondria.
60. Zamzami, N. & Kroemer, G. The mitochondrion in apoptosis: how Pandora's box opens. Nature Rev. Mol. Cell Biol. 2, 67-71 (2001).
61. Marzo, I. et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281, 2027-2031 (1998).
62. Narita, M. et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl Acad. Sci. USA 95, 14681-14686 (1998).
63. Shimizu, S., Narita, M. & Tsujimoto, Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487 (1999).
64. Thomas, D. A., Scorrano, L., Putcha, G. V., Korsmeyer, S. J. & Ley, T. J. Granzyme B can cause mitochondrial depolarization and cell death in the absence of BID, BAX and BAK. Proc. Natl Acad. Sci. USA 98, 14985-14990 (2001).
65. Davis, J. E., Sutton, V. R., Smyth, M. J. & Trapani, J. A. Dependence of granzyme-B-mediated cell death on a pathway regulated by Bcl-2 or its viral homolog, BHRF1. Cell. Death Differ. 7, 973-983 (2000).
66. Sutton, V. R., Vaux, D. L. & Trapani, J. A. Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes. J. Immunol. 158, 5783-5790 (1997).
67. Vaux, D. L., Aguila, H. L. & Weissman, I. L. Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell-mediated killing. Int. Immunol. 4, 821-824 (1992).
68. Scaffidi, C. et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687 (1998).
69. Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H. & Ley, T. J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76, 977-987 (1994). Granzyme-B-deficient cells are defective in rapid DNA fragmentation.
70. Shresta, S., MacIvor, D. M., Heusel, J. W., Russell, J. H. & Ley, T. J. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc. Natl Acad. Sci. USA 92, 5679-5683 (1995).
71. Enari, M. et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50 (1998).
72. Li, L. Y., Luo, X. & Wang, X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412, 95-99 (2001).
73. Liu, X., Zou, H., Slaughter, C. & Wang, X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175-184 (1997).
74. Sharif-Askari, E. et al. Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. EMBO J. 20, 3101-3113 (2001).
75. Thomas, D. A., Du, C., Xu, M., Wang, X. & Ley, T. J. DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. Immunity 12, 621-632 (2000).
76. Wolf, B. B., Schuler, M., Echeverri, F. & Green, D. R. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J. Biol. Chem. 274, 30651-30656 (1999).
77. Bird, C. H. et al. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme-B-mediated apoptosis without perturbing the Fas cell-death pathway. Mol. Cell. Biol. 18, 6387-6398 (1998).
78. Medema, J. P. et al. Blockade of the granzyme-B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc. Natl Acad. Sci. USA 98, 11515-11520 (2001).
79. Medema, J. P. et al. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194, 657-667 (2001).
80. Ebnet, K. et al. Granzyme-A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J. 14, 4230-4239 (1995).
81. Shresta, S., Goda, P., Wesselschmidt, R. & Ley, T. J. Residual cytotoxicity and granzyme-K expression in granzyme-A-deficient cytotoxic lymphocytes. J. Biol. Chem. 272, 20236-20244 (1997).
82. Mullbacher, A. et al. Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen ectromelia. Proc. Natl Acad. Sci. USA 93, 5783-5787 (1996). The first report to indicate that granzyme A is necessary for recovery from virus infection by the poxvirus ectromelia.
83. + cell granules, restricts the spread of herpes simplex virus in the peripheral nervous systems of experimentally infected mice. J. Virol. 74, 1029-1032 (2000).
84. Simon, M. M. et al. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A × B double-knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J. Exp. Med. 186, 1781-1786 (1997).
85. Beresford, P. J., Xia, Z., Greenberg, A. H. & Lieberman, J. Granzyme A loading induces rapid cytoysis and a novel form of DNA damage independently of caspase activation. Immunity 10, 585-594 (1999). Granzyme A mediates a new form of DNA damage.
86. Nakajima, H., Park, H. L. & Henkart, P. A. Synergistic roles of granzymes A and B in mediating target-cell death by rat basophilic leukemia mast-cell tumors also expressing cytolysin/perforin. J. Exp. Med. 181, 1037-1046 (1995).
87. Zhang, D. et al. Induction of rapid histone degradation by the cytotoxic T lymphocyte protease granzyme A. J. Biol. Chem. 276, 3683-3690 (2001).
88. Zhang, D., Beresford, P. J., Greenberg, A. H. & Lieberman, J. Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis. Proc. Natl Acad. Sci. USA 98, 5746-5751 (2001).
89. Tortorella, D., Gerurz, B., Furman, M. H., Schust, D. J. & Ploegh, H. L. Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926 (2000). A comprehensive review of viral strategies of immune evasion.
90. Loenen, W. A., Bruggeman, C. A. & Wiertz, E. J. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin. Immunol. 13, 41-49 (2001).
91. Roulston, A., Marcellus, R. C. & Branton, P. E. Viruses and apoptosis. Annu. Rev. Microbiol. 53, 577-628 (1999).
92. Bump, N. J. et al. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269, 1885-1888 (1995).
93. Tewari, M. & Dixit, V. M. Fas- and tumor-neorosis-factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270, 3255-3260 (1995).
94. Everett, H. et al. M11L: a novel mitochondrial-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J. Exp. Med. 191, 1487-1498 (2000).
95. Goldmacher, V. S. et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl Acad. Sci USA. 96, 12536-12541 (1999). The first demonstration of a new mitochondria-localized anti-apoptotic protein encoded by human cytomegalovirus.
96. Wasilenko, S. T., Meyers, A. F., Vander Helm, K. & Barry, M. Vaccinia-virus infection disarms the mitochondrion-mediated pathway of the apoptotic cascade by modulating the permeability transition pore. J. Virol. 75, 11437-11448 (2001).
97. Andrade, F. et al. Adenovirus L4-100K assembly protein is a granzyme-B substrate that potently inhibits granzyme-B-mediated cell death. Immunity 14, 751-761 (2001).
98. Krensky, A. M. Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Biochem. Pharmacol. 59, 317-320 (2000).
99. Stenger, S., Rosat, J. R., Bloom, B. R., Krensky, A. M. & Modlin, R. L. Granulysin: a lethal weapon of cytolytic T cells. Immunol. Today 20, 390-394 (1999). This article reviews the role of granulysin in CTL-mediated killing.
100. Stenger, S. et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121-125 (1998).
101. Thoma-Uszynski, S., Stenger, S. & Modlin, R. L. CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target-cell nuclear apoptosis. J. Immunol. 165, 5773-5779 (2000).
102. Ernst, W. A. et al. Granulysin, a T-cell product, kills bacteria by altering membrane permeability. J. Immunol. 165, 7102-7108 (2000).
103. Gamen, S. et al. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J. Immunol. 161, 1758-1764 (1998).
104. Kaspar, A. A. et al. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J. Immunol. 167, 350-356 (2001).
105. Pardo, J. et al. A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J. Immunol. 167, 1222-1229 (2001).
106. Pena, S. V., Hanson, D. A., Carr, B. A., Goralski, T. J. & Krensky, A. M. Processing, subcellular localization and function of 519 (granulysin), a human late T-cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 158, 2680-2688 (1997).
107. Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650-652 (1994).
108. Pham, C. T. & Ley, T. J. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl Acad. Sci. USA 96, 8627-8632 (1999).
109. Metkar, S. S. et al. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme-B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 16, 417-428 (2002).
110. Russell, J. H. & Ley, T. J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20, 323-370 (2002).